Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-004785)

Filing Details

Accession Number:: 0001179110-17-004785
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-17 11:53:24
Reporting Period:: 2017-03-15

Filing Date:: 2017-03-17
Accepted Time:: 2017-03-17 11:53:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1650664	Editas Medicine Inc.	EDIT	Biological Products, (No Disgnostic Substances) (2836)	464097528

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658390	Alexandra Glucksmann	C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-03-15	1,000	$0.65	118,788	No	4	M	Direct
Common Stock	Disposition	2017-03-15	1,000	$26.41	117,788	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2017-03-15	1,000	$0.00	1,000	$0.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,461		2025-04-14	No	4	M	Direct

Footnotes

The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016.
This option was granted on April 16, 2015 and is scheduled to vest over four years with 25% of the shares having vested on March 9, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through March 9, 2019.